anti-malarial drugs market growth,trends,size,and competitive analysis 2020 pharmiweb.com

Malaria is common infectious disease caused by the protozoan parasite, Plasmodium parasites. The bite of an infected female Anopheles mosquito transmits a parasite to the person’s body, which then enters into the person’s liver where the production of parasite occurs. Human malaria are generally caused by five types of plasmodium parasites, including P. falciparum, P. malariae, P. ovale, P. vivax, and P.knowlesi. Among these, P. falciparum and P. vivax are the most dangerous species of parasite causing highest number of malaria mortality. Early diagnosis and efficient treatment are crucial measures to control malaria. Different types of drugs such as quinine, chloroquine, mefloquine, proguanil, primaquine, and others are used in the treatment of malaria. Moreover, some combination drugs such as Pyrimethamine & sulfadoxine, Artemether & lumefantrine, and others are also prescribed for treating the disease.

Read more informations: https://www.pharmiweb.com/press-release/2021-01-15/anti-malarial-drugs-market-value-to-worth-over-us-1-1830-million-at-44-cagr-growth-rate-by-2027